METHOD AND SYSTEM FOR MICROBIOME-DERIVED DIAGNOSTICS AND THERAPEUTICS FOR AUTOMIMMUNE SYSTEM CONDITIONS
Patent №
US 10,073,952
Granted
2018-09-11
Filed 2016
Owner
UBIOME, INC.
Lab
—
AI components
5
ml · nlp · kr · planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
15098027
A method for at least one of characterizing, diagnosing, and treating an autoimmune disorder in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the autoimmune condition based upon features extracted from at least one of the microbiome composition dataset and the microbiome functional diversity dataset; based upon the characterization, generating a therapy model configured to correct the autoimmune condition; and at an output device associated with the subject, promoting a therapy to the subject based upon the characterization and the therapy model.
AI classification
Ownership
UBIOME, INC.
assignment · 384810018
Assignors
APTE, ZACHARY, ALMONACID, DANIEL, RICHMAN, JESSICA, BELBAHANI, SIAVOSH REZVAN
On an employer assignment, the assignors are typically the inventors.